Literature DB >> 6122949

Probucol and the QT interval.

G Troendle, J Guerigian, S Sobel, M Johnson.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6122949     DOI： 10.1016/s0140-6736(82)92240-1

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

2.  Managing hyperlipidaemias.

Authors:  B M Buckley; A M Bold
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

3.  Electrocardiographic effects of probucol. A controlled prospective clinical trial.

Authors:  C A Dujovne; F Atkins; B Wong; S DeCoursey; P Krehbiel; S B Chernoff
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 4.  Probucol. A reappraisal of its pharmacological properties and therapeutic use in hypercholesterolaemia.

Authors:  M M Buckley; K L Goa; A H Price; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

5.  Factors related to QT interval prolongation during probucol treatment.

Authors:  Y Ohya; K Kumamoto; I Abe; Y Tsubota; M Fujishima
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.